Upload

Loading icon Loading...

This video is unavailable.

Mayo Clinic Researchers Find Survival Improves When Herceptin is Used with Chemotherapy

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to like Mayo Clinic's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to dislike Mayo Clinic's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add Mayo Clinic's video to your playlist.

Uploaded on Dec 7, 2009

Herceptin has proven to be a life-saving drug for women with HER2+ breast cancer, which makes up 20 percent to 25 percent of all cases. But it has not been known whether the agent should be given with, or after, chemotherapy in women who have already had surgery to remove tumors.
The answer is now known, based on a key trial headed by Mayo Clinic researchers, who tested the two different regimens head-to-head. Lead investigator Edith Perez, M.D., Professor of Medicine at Mayo Clinics campus in Jacksonville, Fla., shares more on this study.

Loading icon Loading...

Loading icon Loading...

Loading icon Loading...

The interactive transcript could not be loaded.

Loading icon Loading...

Loading icon Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

Loading icon Loading...

Loading...
Working...
to add this to Watch Later

Add to